Lovaza Sales Data

Rank 59 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Lovaza U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 59 (1) 2.90% -5.05%
Q3 2013 58 (8) -4.96% -8.81%
Q2 2013 50 (2) -1.47% -1.72%
Q1 2013 52 (1) 0.70% -4.33%
Q4 2012 51 (2) -0.19% -0.42%
Q3 2012 53 (7) 8.82% 6.39%
Q2 2012 60 (7) 2.13% 0.78%
Q1 2012 67 (1) -1.81% -4.53%
Q4 2011 68 (1) 5.34% 2.88%
Q3 2011 67 (9) -8.96% -8.75%
Q2 2011 58 (7) 3.98% 4.00%
Q1 2011 65

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web4)